Alzamend Neuro ALZN
NASDAQ ALZN
$1.13 +0.01 (+0.89%)
As of: Oct 23, 2026 · 3:58 PM EDT

Alzamend Neuro (ALZN) Net Debt Issuances and Repayments (2020 - 2021)

Updated

Analysis

Alzamend Neuro (ALZN) Net Debt Issuances and Repayments (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -4.36 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -2.00 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 64.00 Mn
10 Alzamend Neuro 5.20 Mn -10.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2021 40,000.00
Oct 31, 2020 285,100.00
Jul 31, 2020 77,010.00
API Access

Alzamend Neuro Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=ALZN&period=max&api_key=YOUR_API_KEY